Macquarie Group’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-127,275
Closed -$4.02M 1642
2025
Q2
$4.02M Sell
127,275
-150,243
-54% -$4.83M ﹤0.01% 1030
2025
Q1
$9.21M Sell
277,518
-14,032
-5% -$503K 0.01% 827
2024
Q4
$10M Sell
291,550
-1,197
-0.4% -$41.1K 0.01% 803
2024
Q3
$11.7M Sell
292,747
-3,133
-1% -$110K 0.01% 800
2024
Q2
$8.93M Sell
295,880
-4,026
-1% -$121K 0.01% 836
2024
Q1
$10.1M Sell
299,906
-275,646
-48% -$8.85M 0.01% 823
2023
Q4
$18.6M Sell
575,552
-376,841
-40% -$10.5M 0.02% 680
2023
Q3
$31.2M Buy
952,393
+50,865
+6% +$1.77M 0.04% 545
2023
Q2
$31.7M Buy
901,528
+72,859
+9% +$2.52M 0.04% 556
2023
Q1
$27.1M Buy
828,669
+126,575
+18% +$5.76M 0.03% 595
2022
Q4
$38.7M Buy
702,094
+41,250
+6% +$2.27M 0.05% 516
2022
Q3
$29.3M Buy
660,844
+30,633
+5% +$1.49M 0.04% 584
2022
Q2
$30.7M Buy
630,211
+224,843
+55% +$10.1M 0.03% 600
2022
Q1
$19.7K Buy
+405,368
New +$16.5M 0.02% 765

Other funds holding HRMY